Unichem Laboratories soars on reporting 73% surge in Q2 net profit

22 Oct 2012 Evaluate

Unichem Laboratories is currently trading at Rs. 193.85, up by 5.60 points or 2.97% from its previous closing of Rs. 188.25 on the BSE.

The scrip opened at Rs. 191.10 and has touched a high and low of Rs. 197.10 and Rs. 191.10 respectively. So far 52019 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 203.35 on 25-Sep-2012 and a 52 week low of Rs. 101.15 on 13-Dec-2011.

Last one week high and low of the scrip stood at Rs. 197.10 and Rs. 173.95 respectively. The current market cap of the company is Rs. 2301.22 crore.

The promoters holding in the company stood at 49.53% while Institutions and Non-Institutions held 13.95% and 36.52% respectively.

Drug firm Unichem Laboratories has reported 73.22% rise in its net profit at Rs 35.07 crore for the second quarter ended September 30, 2012, mainly on account of robust sales. The company had posted net profit of Rs 19.14 crore for the quarter ended September 30, 2011. Total income of the company rose to Rs 264.24 crore for the quarter under consideration, up by 32.90% compared to Rs 198.83 crore for the corresponding period previous fiscal.

Unichem Laboratories is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs). The company was promoted by the late Amrut Mody, a pioneer in the Indian pharmaceuticals business.

Unichem Lab Share Price

439.15 -8.00 (-1.79%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×